More about
Cytokine Release Syndrome
News
August 30, 2022
4 min read
Save
CAR-T will ‘play a very important role’ in multiple myeloma treatment landscape
News
August 27, 2021
3 min read
Save
COVID-19-driven shortage of tocilizumab may impact delivery of CAR T-cell therapy
News
April 22, 2021
2 min read
Save
Lenzilumab before CAR-T induces high response rates without severe toxicities
News
April 05, 2021
3 min read
Save
Anakinra shows promise as steroid-sparing agent for CAR T-cell therapy-related toxicities
News
March 10, 2021
3 min read
Save
Guidelines provide consensus on management of CAR T-cell therapy-related toxicities
News
January 15, 2021
1 min watch
Save
VIDEO: CAR-T techniques could be applied to COVID-19 management
News
October 15, 2020
3 min read
Save
CAR-T-associated cardiac toxicity ‘limited and reversible’ in younger patients with ALL
News
September 24, 2020
3 min read
Save
CAR-T plus pembrolizumab shows ‘superior’ safety, promising responses in advanced lymphoma
News
September 18, 2020
5 min read
Save
Limiting severe toxicity, mortality after CAR T-cell therapy

In this installment of In Practice, Marco L. Davila, MD, PhD, and Rawan G. Faramand, MD, of H. Lee Moffitt Cancer Center and Research Institute in Tampa, discuss the importance of developing a patient-specific management strategy to limit severe toxicities and mortality after chimeric antigen receptor T-cell therapy.
News
August 18, 2020
2 min read
Save